Rapid effects of different lipid-lowering drugs on PCSK9 in humans

Author： Liu Jun   Guo Yuan-Lin   Xu Rui-Xia   Li Jian-Jun  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.5, 2013-10, pp. : 519-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-Lowering Drugs: Are Adverse Effects Predictable and Reversible?

By  

Cardiology, Vol. 97, Iss. 3, 2002-06 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe

By Bays Harold   Rhyne James   Abby Stacey   Lai Yu-Ling   Jones Michael  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2191-2200

Informa Healthcare

Access to resources Recommend Favorite

Cancer mortality according to lipid-lowering drugs and lipoproteins in a general population

By Bérard E.   Bongard V.   Dallongeville J.   Arveiler D.   Ruidavets J.B.   Ferrières J.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1963-1971

Informa Healthcare

Access to resources Recommend Favorite

Why do sales of lipid-lowering drugs vary between counties in Norway?

By Hartz Ingeborg   Njølstad Inger   Furu Kari   Skurtveit Svetlana   Elise Eggen Anne  

Scandinavian Journal of Primary Health Care, Vol. 24, Iss. 2, 2006-06 ,pp. : 115-121

Informa Healthcare

Access to resources Recommend Favorite

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh   Lip Gregory YH  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite